Navigation Links
UBM TechInsights Expands Presence in the Medical Devices Sector
Date:9/7/2010

OTTAWA, Ontario, Sept. 7 /PRNewswire/ -- UBM TechInsights is pleased to announce it has hired Gary Johnson as the new Vice President, Business Development, Medical Devices. In this role Mr. Johnson will be responsible for the continued expansion of company's business in the Medical Devices sector.

(Photo:  http://photos.prnewswire.com/prnh/20100907/SF60618)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100907/SF60618)

Mr. Johnson comes to UBM TechInsights from Texas Instruments where he worked for the past three years as Global Medical Sales Manager.  In that role he led the strategy and business development of the company's entry in to the Implantable Medical market creating partnerships with key accounts that resulted in valuable design wins.

Prior to Texas Instruments Mr. Johnson served as Director of Medical Business Development at AMI Semiconductor where he managed the business development activities of their top medical customers.  He also worked with the engineering and medical business units to map new product technology roadmaps to short and long term sales objectives.  Mr. Johnson received his Bachelor of Science - Electrical Engineering from the University of Minneapolis, Minnesota.

"With the increased availability of consumer grade medical devices, companies need a partner like UBM TechInsights who possess both the technical and intellectual property management expertise to support their technical innovation, cost control and IP management efforts. Gary is an experienced strategist with a strong technical background," said Harry Page, chief executive officer, UBM TechInsights "he will serve a vital role in expanding our presence in the growing medical devices marketplace.

UBM TechInsights provides technical analyses and IP services to companies operating in the electronics marketplace.  The company is an acknowledged thought leader in intellectual property rights management and performs teardowns of medical devices.

About UBM TechInsights

UBM TechInsights is the preeminent firm for the provision of sophisticated information and advice to technology companies. We assist in the management of their technology and intellectual property portfolios, ensuring the reduction of risk and maximizing return on investment. Our leadership position is founded upon our commitment to the utmost integrity, and sustained by the ongoing investment and acquisition of the knowledge and capabilities necessary to meet our clients' evolving needs. When companies need assistance in managing their most complex technology or IP challenges, they turn to UBM TechInsights for assured results. For more information about UBM TechInsights, go to www.ubmtechinsights.com.


'/>"/>
SOURCE UBM TechInsights
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... March 30, 2017  Lannett Company, Inc. (NYSE: ... made a $25 million payment against its existing revolving ... combined with the $75 million payment we made earlier ... million in annualized cash interest expense, at current rates" ... Lannett.  "Our business is solid and we continue to ...
(Date:3/30/2017)... Revenue Prospects by Product Type (Metered Dose ... Geography Respiratory Inhalers - our new study reveals trends, ... market heading? If you are involved in this sector you must ... the potential revenues streams to 2027, assessing data, trends, opportunities and ... ...
(Date:3/30/2017)... 30, 2017  Purcell Julie & Lefkowitz LLP, a class ... a potential breach of fiduciary duty claim involving the board ... ). If you are a shareholder of ... this investigation, free of charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, ... conference “ Preventing Hospital Readmissions Through Discharge Planning ” with noted expert Sue ... ET. This conference discusses strategies to prevent readmissions in light of the most ...
(Date:3/29/2017)... ... 29, 2017 , ... During the last week of March, Chad Kawa, MD ... individuals in the local community. , Colon cancer is the second leading cause ... cancer while it is small, confined and easier to treat. If you are 50 ...
(Date:3/29/2017)... San Diego, CA (PRWEB) , ... March 29, 2017 , ... ... meningiomas(1,2), and up to 300,000 people each year develop other types of metastatic brain ... spread quickly throughout the brain(3). As efforts focus on finding more effective treatment options, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based ... Pet Protect Law that assists dog owners in creating legally-enforceable pet trusts for ... taking the natural next step to protect their new companion. Says Evan Dunbar, CEO ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL ... that Mercy Medical Center will serve as the official title sponsor of the Baltimore ... June 25, 2017, thousands of women will walk or run the course around the ...
Breaking Medicine News(10 mins):